Efflux transport of chrysin and apigenin sulfates in HEK293 cells overexpressing SULT1A3: The role of multidrug resistance-associated protein 4 (MRP4/ABCC4).

[1]  Xiaotong Zhou,et al.  Multidrug Resistance-Associated Protein 4 (MRP4/ABCC4) Controls Efflux Transport of Hesperetin Sulfates in Sulfotransferase 1A3–Overexpressing Human Embryonic Kidney 293 Cells , 2015, Drug Metabolism and Disposition.

[2]  Baojian Wu,et al.  Characterization of Chrysin Glucuronidation in UGT1A1-Overexpressing HeLa Cells: Elucidating the Transporters Responsible for Efflux of Glucuronide , 2015, Drug Metabolism and Disposition.

[3]  Baojian Wu,et al.  Stable knock-down of efflux transporters leads to reduced glucuronidation in UGT1A1-overexpressing HeLa cells: the evidence for glucuronidation-transport interplay. , 2015, Molecular pharmaceutics.

[4]  K. Brouwer,et al.  Role of Multidrug Resistance–Associated Protein 4 in the Basolateral Efflux of Hepatically Derived Enalaprilat , 2014, Drug Metabolism and Disposition.

[5]  A. Pandey,et al.  Chemistry and Biological Activities of Flavonoids: An Overview , 2013, TheScientificWorldJournal.

[6]  M. James,et al.  Interactions of cytosolic sulfotransferases with xenobiotics , 2013, Drug metabolism reviews.

[7]  Taijun Yin,et al.  Breast Cancer Resistance Protein (ABCG2) Determines Distribution of Genistein Phase II Metabolites: Reevaluation of the Roles of ABCG2 in the Disposition of Genistein , 2012, Drug Metabolism and Disposition.

[8]  Taijun Yin,et al.  A New Strategy to Rapidly Evaluate Kinetics of Glucuronide Efflux by Breast Cancer Resistance Protein (BCRP/ABCG2) , 2012, Pharmaceutical Research.

[9]  J. Morrow,et al.  SULT1A3-mediated regiospecific 7-O-sulfation of flavonoids in Caco-2 cells can be explained by the relevant molecular docking studies. , 2012, Molecular pharmaceutics.

[10]  M. Mieth,et al.  Identification of drugs and drug metabolites as substrates of multidrug resistance protein 2 (MRP2) using triple‐transfected MDCK‐OATP1B1‐UGT1A1‐MRP2 cells , 2012, British journal of pharmacology.

[11]  K. Hillgren,et al.  Efflux Transport Is an Important Determinant of Ethinylestradiol Glucuronide and Ethinylestradiol Sulfate Pharmacokinetics , 2011, Drug Metabolism and Disposition.

[12]  S. Basu,et al.  First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics. , 2011, Journal of pharmaceutical sciences.

[13]  George K Acquaah-Mensah,et al.  Subcellular Location and Molecular Mobility of Human Cytosolic Sulfotransferase 1C1 in Living Human Embryonic Kidney 293 Cells , 2011, Drug Metabolism and Disposition.

[14]  A. D. Rodrigues,et al.  Transporter Studies with the 3-O-Sulfate Conjugate of 17α-Ethinylestradiol: Assessment of Human Liver Drug Transporters , 2010, Drug Metabolism and Disposition.

[15]  A. D. Rodrigues,et al.  Transporter Studies with the 3-O-Sulfate Conjugate of 17α-Ethinylestradiol: Assessment of Human Kidney Drug Transporters , 2010, Drug Metabolism and Disposition.

[16]  M. Hu,et al.  Breast Cancer Resistance Protein (BCRP) and Sulfotransferases Contribute Significantly to the Disposition of Genistein in Mouse Intestine , 2010, The AAPS Journal.

[17]  H. Glatt,et al.  Phase II Metabolism of Hesperetin by Individual UDP-Glucuronosyltransferases and Sulfotransferases and Rat and Human Tissue Samples , 2010, Drug Metabolism and Disposition.

[18]  T. Tracy,et al.  Glucuronidation of Dihydrotestosterone and trans-Androsterone by Recombinant UDP-Glucuronosyltransferase (UGT) 1A4: Evidence for Multiple UGT1A4 Aglycone Binding Sites , 2010, Drug Metabolism and Disposition.

[19]  K. Audus,et al.  MRP isoforms and BCRP mediate sulfate conjugate efflux out of BeWo cells. , 2010, International journal of pharmaceutics.

[20]  M. Uhlén,et al.  Endogenous Gene and Protein Expression of Drug-Transporting Proteins in Cell Lines Routinely Used in Drug Discovery Programs , 2009, Drug Metabolism and Disposition.

[21]  Jackie C Bloomer,et al.  Quantitative Evaluation of the Expression and Activity of Five Major Sulfotransferases (SULTs) in Human Tissues: The SULT “Pie” , 2009, Drug Metabolism and Disposition.

[22]  U. Bickmeyer,et al.  Inhibition of multidrug/xenobiotic resistance transporter by MK571 improves dye (Fura 2) accumulation in crustacean tissues from lobster, shrimp, and isopod. , 2009, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.

[23]  T. Zhou,et al.  Sulfation of dietary flavonoids by human sulfotransferases , 2009, Xenobiotica; the fate of foreign compounds in biological systems.

[24]  P. Krajcsi,et al.  Utilization of membrane vesicle preparations to study drug–ABC transporter interactions , 2008, Expert opinion on drug metabolism & toxicology.

[25]  Rosalinde Masereeuw,et al.  Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules. , 2008, Trends in pharmacological sciences.

[26]  Shufeng Zhou,et al.  Structure, function and polymorphism of human cytosolic sulfotransferases. , 2008, Current drug metabolism.

[27]  Simone Florian,et al.  Identification and localization of soluble sulfotransferases in the human gastrointestinal tract. , 2007, The Biochemical journal.

[28]  M. Hu,et al.  Natural polyphenol disposition via coupled metabolic pathways , 2007, Expert opinion on drug metabolism & toxicology.

[29]  S. Nagar,et al.  Variable Sulfation of Dietary Polyphenols by Recombinant Human Sulfotransferase (SULT) 1A1 Genetic Variants and SULT1E1 , 2007, Drug Metabolism and Disposition.

[30]  Rafael Najmanovich,et al.  Structural and Chemical Profiling of the Human Cytosolic Sulfotransferases , 2007, PLoS biology.

[31]  H. Kroemer,et al.  Organic Anion Transporting Polypeptide 2B1 and Breast Cancer Resistance Protein Interact in the Transepithelial Transport of Steroid Sulfates in Human Placenta , 2007, Drug Metabolism and Disposition.

[32]  D. Nimmagadda,et al.  Cellular Localization Studies on Human Estrogen Sulfotransferase SULT1E1 in Human Embryonic Kidney 293 Cells , 2007, Drug Metabolism and Disposition.

[33]  Kim L R Brouwer,et al.  The Important Role of Bcrp (Abcg2) in the Biliary Excretion of Sulfate and Glucuronide Metabolites of Acetaminophen, 4-Methylumbelliferone, and Harmol in Mice , 2006, Molecular Pharmacology.

[34]  K. Brouwer,et al.  Evaluation of the Role of Multidrug Resistance-Associated Protein (Mrp) 3 and Mrp4 in Hepatic Basolateral Excretion of Sulfate and Glucuronide Metabolites of Acetaminophen, 4-Methylumbelliferone, and Harmol in Abcc3–/– and Abcc4–/– Mice , 2006, Journal of Pharmacology and Experimental Therapeutics.

[35]  Kim L. R. Brouwer,et al.  Differential Involvement of Mrp2 (Abcc2) and Bcrp (Abcg2) in Biliary Excretion of 4-Methylumbelliferyl Glucuronide and Sulfate in the Rat , 2006, Journal of Pharmacology and Experimental Therapeutics.

[36]  Jennifer L. Martin,et al.  Human sulfotransferases and their role in chemical metabolism. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[37]  X. Jia,et al.  Coupling of conjugating enzymes and efflux transporters: impact on bioavailability and drug interactions. , 2005, Current drug metabolism.

[38]  Yuichi Sugiyama,et al.  Role of Breast Cancer Resistance Protein (Bcrp1/Abcg2) in the Extrusion of Glucuronide and Sulfate Conjugates from Enterocytes to Intestinal Lumen , 2005, Molecular Pharmacology.

[39]  Mariël Brok,et al.  Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump. , 2004, Blood.

[40]  Chi‐Huey Wong,et al.  Sulfotransferases: Structure, Mechanism, Biological Activity, Inhibition, and Synthetic Utility , 2004 .

[41]  Chi‐Huey Wong,et al.  Sulfotransferases: structure, mechanism, biological activity, inhibition, and synthetic utility. , 2004, Angewandte Chemie.

[42]  R. Weinshilboum,et al.  A proposed nomenclature system for the cytosolic sulfotransferase (SULT) superfamily. , 2004, Pharmacogenetics.

[43]  R. Weinshilboum,et al.  Human cytosolic sulfotransferase database mining: identification of seven novel genes and pseudogenes , 2004, The Pharmacogenomics Journal.

[44]  Huimin Lin,et al.  Metabolism of Flavonoids via Enteric Recycling: Mechanistic Studies of Disposition of Apigenin in the Caco-2 Cell Culture Model , 2003, Journal of Pharmacology and Experimental Therapeutics.

[45]  J. Schellens,et al.  Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C. , 2002, Molecular cancer therapeutics.

[46]  J. Wijnholds,et al.  MRP6 (ABCC6) Detection in Normal Human Tissues and Tumors , 2002, Laboratory Investigation.

[47]  C. Funk,et al.  Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat. , 2001, Molecular pharmacology.

[48]  R. J. Anderson,et al.  Sulfation of iodothyronines by human sulfotransferase 1C1 (SULT1C1)*. , 2000, Biochemical pharmacology.

[49]  H. Glatt,et al.  Sulfotransferases in the bioactivation of xenobiotics. , 2000, Chemico-biological interactions.

[50]  C. Falany,et al.  Molecular cloning and expression of novel sulphotransferase-like cDNAs from human and rat brain. , 2000, The Biochemical journal.

[51]  H. Glatt.  An overview of bioactivation of chemical carcinogens. , 2000, Biochemical Society transactions.

[52]  T. Walle,et al.  Transport of the flavonoid chrysin and its conjugated metabolites by the human intestinal cell line Caco-2. , 1999, Biochemical pharmacology.

[53]  T. Ebner,et al.  Activation of human cytochrome P-450 3A4-catalyzed meloxicam 5'-methylhydroxylation by quinidine and hydroquinidine in vitro. , 1999, The Journal of pharmacology and experimental therapeutics.

[54]  C. Klaassen,et al.  The importance of 3‘‐phosphoadenosine 5‘‐phosphosulfate (PAPS) in the regulation of sulfation , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[55]  A. Buhl,et al.  Minoxidil sulfate is the active metabolite that stimulates hair follicles. , 1990, The Journal of investigative dermatology.

[56]  雄一 杉山,et al.  血液脳関門におけるMULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 4 (MRP4)の重要性の検討 , 2009 .

[57]  Mariël Brok,et al.  Imatinib mesylate ( STI 571 ) is a substrate for the breast cancer resistance protein ( BCRP ) / ABCG 2 drug pump , 2004 .

[58]  S. Kadota,et al.  Sulfation of environmental estrogens by cytosolic human sulfotransferases. , 2002, Drug metabolism and pharmacokinetics.